Literature DB >> 35165427

Effect of enteral ecoimmunonutrition support for patients undergoing hepatectomy: A meta-analysis of randomized controlled trials.

Xinrong Chen1, Dan Wang1, Shiqi Liang1, Jie Yang2, Ka Li3.   

Abstract

BACKGROUND: Whether to conduct enteral ecoimmunonutrition (EEIN) in patients undergoing hepatectomy remains controversial. This study aimed to systematically explore the efficacy and safety of EEIN in patients undergoing hepatectomy. SUBJECT: We performed searches in the Embase, PubMed, Medline, Cochrane Library, Chinese Scientific Journal Database (VIP), Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases.
RESULTS: A total of 9 randomized controlled trials (705 patients) were included. The meta-analysis revealed a significantly shorter time to first postoperative flatus (h) (MD, -14.60; 95% CI, -16.06~-13.15; P < 0.00001); lower levels of alanine aminotransferase (µmol/L) (MD, -22.26; 95% CI, -28.42~-16.10; P < 0.00001), aspartate transaminase (µmol/L) (MD, -53.79; 95% CI, -57.37~-50.21; P < 0.00001), total bilirubin (µmol/L) (MD, -16.28; 95% CI, -17.77~-14.79; P < 0.00001), direct bilirubin (µmol/L) (MD, -8.77; 95% CI, -9.65~-7.88; P < 0.00001), endotoxin (ng/L) (MD, -0.78; 95% CI, -0.88~-0.68; P < 0.00001), tumor necrosis factor-α (pg/ml) (MD, -79.69; 95% CI, -99.90~-59.49; P < 0.00001), and interleukin-6 (pg/ml) (MD, -46.29; 95% CI, -50.24~-42.34; P < 0.00001); and higher levels of immunoglobulin A (g/L) (MD, 0.24; 95% CI, 0.14~0.35; P < 0.00001), immunoglobulin G (g/L) (MD, 1.52; 95% CI, 1.22~1.82; P < 0.00001), and immunoglobulin M (g/L) (MD, 0.12; 95% CI, 0.05~0.20; P = 0.0007) in the EEIN group than in the enteral or parenteral nutrition (EN/PN) groups.
CONCLUSION: Enteral ecoimmunonutrition support in patients undergoing hepatectomy may effectively protect liver function, reduce serum endotoxin levels and inflammatory factors, improve the immune function of patients, and promote the recovery of postoperative gastrointestinal function, which is worthy of clinical application.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35165427     DOI: 10.1038/s41430-022-01073-x

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.884


  21 in total

1.  Failure to rescue as a source of variation in hospital mortality after hepatic surgery.

Authors:  G Spolverato; A Ejaz; O Hyder; Y Kim; T M Pawlik
Journal:  Br J Surg       Date:  2014-04-23       Impact factor: 6.939

2.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

3.  Short- and long-term impact of reoperation for complications after major hepatectomy for hepatocellular carcinoma.

Authors:  Wong Hoi She; Albert C Y Chan; Tan To Cheung; Kenneth S H Chok; Wing Chiu Dai; See Ching Chan; Chung Mau Lo
Journal:  Surgery       Date:  2016-08-03       Impact factor: 3.982

4.  Therapeutic Effect of Enteral Nutrition Supplemented with Probiotics in the Treatment of Severe Craniocerebral Injury: A Systematic Review and Meta-Analysis.

Authors:  Tianjiao Du; Xiyue Jing; Sirong Song; Shan Lu; Lixia Xu; Xiaoguang Tong; Hua Yan
Journal:  World Neurosurg       Date:  2020-04-24       Impact factor: 2.104

5.  Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma.

Authors:  Kosei Takagi; Takahito Yagi; Yuzo Umeda; Susumu Shinoura; Ryuichi Yoshida; Daisuke Nobuoka; Takashi Kuise; Hiroyuki Araki; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

Review 7.  Preoperative optimization for major hepatic resection.

Authors:  Sarah Walcott-Sapp; Kevin G Billingsley
Journal:  Langenbecks Arch Surg       Date:  2017-11-18       Impact factor: 3.445

8.  Early enteral and parenteral nutritional support after hepatectomy in patients with hepatic carcinoma: a systematic review and meta-analysis.

Authors:  Lin-Ben Gao; He Tian; Xing-Guang Wang; Xiao-Fei Yu; Yan Guan; Ming-Lu Chen; Jian Zhang
Journal:  Onco Targets Ther       Date:  2015-03-10       Impact factor: 4.147

Review 9.  Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity.

Authors:  Yawei Fu; Yadong Wang; Hu Gao; DongHua Li; RuiRui Jiang; Lingrui Ge; Chao Tong; Kang Xu
Journal:  Mediators Inflamm       Date:  2021-01-02       Impact factor: 4.711

Review 10.  Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.

Authors:  Zhefang Wang; Fanyu Liu; Ningbo Fan; Chenghui Zhou; Dai Li; Thomas Macvicar; Qiongzhu Dong; Christiane J Bruns; Yue Zhao
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.